INTRODUCTION

The Pediatric Oncology Fellowship training program is an innovative, collaborative project between Children’s Cancer Hospital Egypt Foundation 57357 (CCHF) and Dana Farber Boston Children’s Cancer and Blood Disorders Center (DF/BC) to develop and conduct a post-doctoral training program in pediatric oncology for physicians from Egypt, and the Middle East and North Africa (MENA) region.

In Egypt, the Middle East and Africa, the total population as of 2011 is 1,578,040,471 for a total of 60 countries representing 22% of the world’s population. 40-50% of whom are under the age of 18. The survival rate for childhood cancer is at best 20 – 30%, which is far below the average of developed countries. These statistics are a clear indication that there is a significant shortage of expertise and resources needed to treat children with cancer in this region.

In the current pool of pediatric oncologists in the region, the majority are insufficiently trained and too few in numbers for the growing population. In a recent Medscape article about cancer incidence in Africa, Mr. Alan Milburn, President of African Oxford Foundation said, “Cancer incidence in Africa is like a runaway train.” Dr. Ian McGrath, a well-known pediatric oncologist, was interviewed reflecting on his long experience in Africa, "You have to be prepared to train and educate the professional staff — select a disease or discipline, and one or more centers, and try to develop those into centers of excellence or reference centers." He also noted that these centers then become resources in their own countries, and serve as training facilities and improve access to diagnosis, treatment, and palliative care in other countries. Foundation Academy 57357 together with physicians from Boston Children’s Hospital (BCH) and Dana-Farber Cancer Institute (DFCI) have already initiated collaborative work geared towards educating the CCHE staff in many areas of clinical care, subspecialty training, and research as well as identifying other beneficial opportunities for cooperation. CCHE staff and regional physicians have already benefited from the guidance and knowledge provided by these physicians. As all three institutions (DFCI, BCH and CCHE Foundation Academy 57357) are highly committed to global outreach based on education and international work, the joint fellowship program will help improve the level of care for the region’s pediatric cancer patients. Upon completion of the fellowship, fellows will receive a certificate from CCHE Foundation Academy 57357 and Dana-Farber Boston Children’s Cancer and Blood Disorders Center (DFBC).

OUR MISSION

The Pediatric Oncology Fellowship training program is an innovative, collaborative project between Children’s Cancer Hospital Egypt Foundation 57357 (CCHF) and Dana Farber Boston Children’s Cancer and Blood Disorders Center (DF/BC) to develop and conduct a post-doctoral training program in pediatric oncology for physicians from Egypt, and the Middle East and North Africa (MENA) region.

In Egypt, the Middle East and Africa, the total population as of 2011 is 1,578,040,471 for a total of 60 countries representing 22% of the world’s population. 40-50% of whom are under the age of 18. The survival rate for childhood cancer is at best 20 – 30%, which is far below the average of developed countries. These statistics are a clear indication that there is a significant shortage of expertise and resources needed to treat children with cancer in this region.

In the current pool of pediatric oncologists in the region, the majority are insufficiently trained and too few in numbers for the growing population. In a recent Medscape article about cancer incidence in Africa, Mr. Alan Milburn, President of African Oxford Foundation said, “Cancer incidence in Africa is like a runaway train.” Dr. Ian McGrath, a well-known pediatric oncologist, was interviewed reflecting on his long experience in Africa, "You have to be prepared to train and educate the professional staff — select a disease or discipline, and one or more centers, and try to develop those into centers of excellence or reference centers." He also noted that these centers then become resources in their own countries, and serve as training facilities and improve access to diagnosis, treatment, and palliative care in other countries. Foundation Academy 57357 together with physicians from Boston Children’s Hospital (BCH) and Dana-Farber Cancer Institute (DFCI) have already initiated collaborative work geared towards educating the CCHE staff in many areas of clinical care, subspecialty training, and research as well as identifying other beneficial opportunities for cooperation. CCHE staff and regional physicians have already benefited from the guidance and knowledge provided by these physicians. As all three institutions (DFCI, BCH and CCHE Foundation Academy 57357) are highly committed to global outreach based on education and international work, the joint fellowship program will help improve the level of care for the region’s pediatric cancer patients. Upon completion of the fellowship, fellows will receive a certificate from CCHE Foundation Academy 57357 and Dana-Farber Boston Children’s Cancer and Blood Disorders Center (DFBC).

GOALS AND OBJECTIVES

The ultimate goal of this combined fellowship training program is to improve the pediatric oncology survival rates and outcomes within Egypt, the Middle East and Africa. To achieve this result, CCHF 57357 and DF/BC have set out to develop an innovative and targeted fellowship program that seeks to increase the number of well-trained pediatric oncologists and improve the quality of care to meet the needs of children with cancer in the region.

Objectives
1. Provide a formal fellowship framework for pediatric oncology training and mentoring for Egyptian, African and Middle Eastern pediatricians in line with international standards.
2. Facilitate knowledge sharing between physicians at Children’s Cancer Hospital Egypt and the Dana-Farber Boston Children’s Cancer and Blood Disorders Center (DF/BC).
3. Create a pool of qualified pediatric oncologists for the implementation of future sub-specialization educational exchange programs.
4. Facilitate access of care to pediatric oncology sub specialty services at DF/BC not available in Egypt, Africa, or the Middle East.
5. Provide rewarding and unique global health opportunities in education, care and research for DFBC/CCHE physicians.
6. Provide CCHF 57357 with a competitive advantage by demonstrating its intent and capability to partner with highly credible and well recognized global leaders in pediatric oncology.
7. Position CCHF 57357 as a leading institution in promoting academic and clinical excellence in Egypt and regionally.
8. Expand on research collaboration between CCHF 57357 and DF/BC, which will ultimately define new standards of care for children with cancer in Egypt and the MENA region.
9. Provide DF/BC with a collaboration opportunity in global healthcare and education.

Establish the concepts of research, standardized treatment protocols and clinical trials as an integral part of pediatric oncology care and practice in Egypt.

SUPPORT

This educational program will be supported financially and administratively by Egypt Cancer Network 57357, (ECN USA) a U.S. nonprofit 501c3 organization based in Los Angeles, The Association of Friends of the National Cancer Institute (AFNCI) and Children’s Cancer Hospital Foundation CCHF 57357 (CCHF).

FELLOWSHIP PEOPLE

Leadership

Program Committee

Combined CCHF 57357 & DF/BC Program Committee roles and responsibilities

The CCHF 57357/DFBC Fellowship Program Committee is responsible for the smooth operation of the Fellowship program as well as the development and implementation of the curriculum and pedagogy.
Responsibilities of the Fellowship Program Committee include the following: General Roles and Responsibilities
1. Mentorship of the fellows.
2. Compliance with all necessary aspects of participation, preparation, and execution of the program, as directed by the fellowship program standard requirements.
3. Implement the search process and candidate interviews and recommend selection of fellows.
4. Address any issues pertinent to admissions, fellow selection, performance issues and the remediation plan.
5. Select expert trainers and mentors.
6. Implement, monitor, and evaluate fellows, trainers and mentors.
7. Oversee daily operations and logistics to ensure the program runs smoothly.
8. Maintain accurate and complete program and fellow files, in compliance with standard requirements.
9. Maintain accurate and complete electronic program and fellow records.
10. Respond promptly to requests for information and updates.
11. Prepare accurate and complete Program Information Form (PIF) to be presented monthly to the steering committee. Oversee and organize the activities of the educational program.
12. Develop educational/ learning schedule and mentorship schedule.
13. Create, implement, and review periodically program-specific policies consistent with institutional policies for fellow selection, evaluation, dismissal, duty hours, and ensure written documentation for any fellow participating in the program, monitor duty hours and reports.
14. Institute oversight mechanisms to ensure that each fellow is fulfilling hospital duty requirements as determined by their mentor.
15. Ensure that all interviewed applicants are provided, at a minimum, a written information sheet containing the terms and conditions of the Fellowship program criteria and benefits, visa policies, and the training agreement.
16. Ensure the implementation of fair policies, procedures, and due process, as established by the sponsoring institution and in compliance with the Fellowship Requirements.
17. Provide appropriate supervision of fellow to allow progressively increasing responsibility, according to his/her level of education, ability, and experience.
18. Manage clinical scheduling of fellows including, but not limited to creating clinical rotation and on-call schedules.
19. Structuring on-call schedules to provide readily available supervision to fellows on duty, and ensure appropriate backup support is available when patient care responsibilities are especially difficult or prolonged:
o Structuring duty hours and on-call time periods so as to focus on the needs of the patient, continuity of care, and the educational needs of the fellows, and to comply with requirements as set by the institutions.

Program Committee Members
• Committee Chair: Dr. Sherif Abouelnaga, General Manager Strategic Support Decision Academy, Research, Internal Affairs and IT, 57357 Group
• Program Director and Co-Chair: Dr. Manal Zamzam Medical Director, 57357 Healthcare Sciences Academy
• Dr. Mark Kieran, MD, Ph.D., Director of Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute and Boston Children’s Hospital Boston; Associate Professor of Pediatrics, Harvard Medical School.
• Dr. Leslie Lehmann, MD, Clinical Director, Pediatric Stem Cell Transplant Program, Dana-Farber Cancer Institute and Boston Children’s Hospital; Assistant Professor of Pediatrics, Harvard Medical School
• Dr. Mohammed Fawzy, Prof. of Pediatric Oncology, CCHE, NCI Egypt
• Dr. Hanafy Ahmed Hafez, Lecturer of Pediatric Oncology CCHE, NCI, Egypt
• Dr. Liliana Goumnerova, MD, Director for Pediatric Neurosurgical Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute; Associate Professor of Neurosurgery, Harvard Medical School
• Dr. Kenneth Cohen, MD, MBA, Director of Pediatric Neuro Oncology, Johns Hopkins Children’s Center; Associate Professor, Johns Hopkins University
• Mohamed Hassanain, Business consultant, Project Manager, CCHE
• Dr. Belqis Aldimshawy, Head of Medical Learning & Development Division

Steering Committee

Steering Committee Roles and Responsibilities

1. Provide direction and guidance to the sub-committees.
2. Ensure conformity to memo of understanding between all parties.
3. Oversee the development of the strategy and long-term vision of fellowship program including marketing of program.
4. Oversee the program design and structure.
5. Select expert trainers and mentors.
6. Implement, monitor, and evaluate mentor and fellowship programs.
7. Assess outcomes and performance of both trainees and trainers.
8. Resolve escalated issues and concerns.
9. Develop and manage program budget.
10. Elect the Members of the Program Committee.
11. Implement the search process for fellows, interview and make selection of fellowship candidates
12. Oversee annual audit and evaluation of the program


Steering Committee Members
• Prof. Dr. Mohamed Hany Hussein, CEO, 57357 Group
• Dr. Sherif Abouelnaga, General Manager Strategic Support Decision Academy, Research, Internal Affairs and IT, 57357 Group
• Dr. Ashraf Saad Zaghloul, Chairman of 57357 Group
• Dr. Tarek Mansour, Chief Medical Officer, CCHE 57357
• Dr. Alaa Haddad, Director Pediatric Oncology Dept., CCHE 57357
• Dr. Lobna Shalaby, Director Pediatric Oncology Dept., National Cancer Institute
• Dr. Mohamed Saad Zaghloul, Director of Radiation Oncology Dept., CCHE 57357
• Dr. Alaa Younis, Director of Pediatric Surgical Oncology Dept., CCHE 57357
• Dr. Hala Taha, Director of Surgical Pathology Dept., CCHE 57357
• Dr. Iman Zaky, Director Radiology Dept., CCHE 57357
• Dr. Magda Azar, Director of Anaesthesia Dept., CCHE 57357
• Dr. Ossama Mossalem, Professor of Public Health, American University of Cairo
• Dr. Mohammad Fahmy, CEO Logic Consulting
• Dr. Liliana Goumnerova, MD, Director for Pediatric Neurosurgical Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute; Associate Professor of Neurosurgery, Harvard Medical School
• Dr. Mark Kieran, MD, Ph.D., Director of Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute and Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School
• Dr. Leslie Lehmann, MD, Clinical Director, Pediatric Stem Cell Transplant Program, Dana-Farber Cancer Institute and Boston Children’s Hospital; Assistant Professor of Pediatrics, Harvard Medical School
• Dr. Michelle Silvera, MD, Neuroradiologist, Boston Children’s Hospital; Assistant Professor of Radiology, Harvard Medical School
• Dr. Carlos Rodriguez-Galindo, MD, Director of Solid Tumor Program, Dana-Farber Cancer Institute and Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School
• Dr. Kenneth Cohen, MD, MBA, Director of Pediatric Neuro Oncology, Johns Hopkins Children’s Center; Associate Professor, Johns Hopkins University
• Dr. Ayman El Sheikh, MD, Fellowship Director of Pediatric Oncology, University of Iowa Children’s Hospital; Assistant Professor of Pediatrics, University of Iowa Medical School.
• Dr. Wael Ewaida, Strategic Consultant to the 57357 Group, Board of Directors
• Dr. Ahmed Taher, CEO Solutions Consulting, Board Member, CCHF Board of Directors
• Dr. Medhat El Medany, CEO Promark Consulting, Board Member, AFNCI
• Dr. Hesham Dinana, CEO Solving Efeso, Project Manager for 57357 Healthcare Sciences Academy